flomics.bsky.social
@flomics.bsky.social
Liquid biopsy & transcriptomics for biomarker discovery in cancer and beyond. Robust science, reproducibility & RNA-based diagnostics. 🌐 https://flomics.com
Pinned
Fresh insights from the Flomics team! 🧬💻

Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.

📄 Read it: www.biorxiv.org/cgi/content/...
Systematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which compromise...
www.biorxiv.org
🫁 This Friday is World Lung Cancer Day.
At Flomics, we’re developing RNA-based liquid biopsy tools for early, non-invasive detection.
Every dataset matters. Every life matters.
🎗️ To patients, families & researchers: we see you, we work for you.
#WorldLungCancerDay #EarlyDetection #Flomics
July 30, 2025 at 12:40 PM
No endless waiting ⏳
No invasive procedures 💉
Just fast, accurate, and early answers ⚡

Our goal: detect cancer early through a simple blood test — powered by RNA🩸🧬

Behind every breakthrough is a dedicated team 🧬💻🧪

#LiquidBiopsy #RNA #CancerDetection #Bioinformatics #PrecisionMedicine #TeamScience
July 22, 2025 at 9:27 AM
Thanks @biorxiv-bioinfo.bsky.social for hosting our new study!
We’ve unpacked the findings in detail — here’s the full thread → bsky.app/profile/flom...
Systematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling https://www.biorxiv.org/content/10.1101/2025.07.10.664092v1
July 16, 2025 at 10:26 AM
Fresh insights from the Flomics team! 🧬💻

Our new preprint is out:
“Systematic cross-study assessment of RNA-Seq workflows for plasma cfRNA profiling”
Is cfRNA the wild west of protocols? We investigated.

📄 Read it: www.biorxiv.org/cgi/content/...
Systematic cross-study assessment of RNA-Seq experimental workflows for plasma cell-free transcriptome profiling
Plasma cell-free RNA (cfRNA) is a promising source of non-invasive biomarkers, but its clinical translation is hindered by technical challenges and a lack of protocol standardization, which compromise...
www.biorxiv.org
July 15, 2025 at 8:39 AM
Something exciting is on the way…⌛
We're bringing RNA-based diagnostics one step closer to the clinic.
Stay tuned — the news drops very soon. 🚀
#LiquidBiopsy #Transcriptomics #Biomarkers #OpenScience
July 10, 2025 at 10:24 AM
👋 Hi Bluesky! We’re Flomics, a biotech company focused on liquid biopsy & transcriptomics.
Passionate about robust science, reproducibility & biomarker discovery.
Excited to join the community — stay tuned for our first big announcement! 🚀
#LiquidBiopsy #Genomics #OpenScience
July 9, 2025 at 3:16 PM